These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22315412)

  • 1. The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY.
    Ezell SA; Polytarchou C; Hatziapostolou M; Guo A; Sanidas I; Bihani T; Comb MJ; Sourvinos G; Tsichlis PN
    Proc Natl Acad Sci U S A; 2012 Mar; 109(10):E613-21. PubMed ID: 22315412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt1, EMSY, BRCA2 and type I IFN signaling: a novel arm of the IFN response.
    Ezell SA; Tsichlis PN
    Transcription; 2012; 3(6):305-9. PubMed ID: 23117821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases.
    Cousineau I; Belmaaza A
    Mol Genet Genomics; 2011 Apr; 285(4):325-40. PubMed ID: 21409565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of EMSY, a novel BRCA2-link protein, is associated with lymph node metastasis and increased tumor size in breast carcinomas.
    Madjd Z; Akbari ME; Zarnani AH; Khayamzadeh M; Kalantari E; Mojtabavi N
    Asian Pac J Cancer Prev; 2014; 15(4):1783-9. PubMed ID: 24641409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic instability of human mammary epithelial cells overexpressing a truncated form of EMSY.
    Raouf A; Brown L; Vrcelj N; To K; Kwok W; Huntsman D; Eaves CJ
    J Natl Cancer Inst; 2005 Sep; 97(17):1302-6. PubMed ID: 16145051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EMSY threonine 207 phospho-site is required for EMSYdriven suppression of DNA damage repair.
    Jelinic P; Eccles LA; Tseng J; Cybulska P; Wielgos M; Powell SN; Levine DA
    Oncotarget; 2017 Feb; 8(8):13792-13804. PubMed ID: 28099152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMSY promoted the growth and migration of ovarian cancer cells.
    Zhao X; Zhou Y; Nie M; Xian S; Chen H; Wen Y; Zhang L; Huang Y; Chen M; Wang S
    Tumour Biol; 2015 Apr; 36(4):3085-92. PubMed ID: 25510665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of EMSY gene in sporadic ovarian cancer.
    Altinisik J; Karateke A; Coksuer H; Ulutin T; Buyru N
    Mol Biol Rep; 2011 Jan; 38(1):359-63. PubMed ID: 20349280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.
    Hughes-Davies L; Huntsman D; Ruas M; Fuks F; Bye J; Chin SF; Milner J; Brown LA; Hsu F; Gilks B; Nielsen T; Schulzer M; Chia S; Ragaz J; Cahn A; Linger L; Ozdag H; Cattaneo E; Jordanova ES; Schuuring E; Yu DS; Venkitaraman A; Ponder B; Doherty A; Aparicio S; Bentley D; Theillet C; Ponting CP; Caldas C; Kouzarides T
    Cell; 2003 Nov; 115(5):523-35. PubMed ID: 14651845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31.
    Viré E; Curtis C; Davalos V; Git A; Robson S; Villanueva A; Vidal A; Barbieri I; Aparicio S; Esteller M; Caldas C; Kouzarides T
    Mol Cell; 2014 Mar; 53(5):806-18. PubMed ID: 24582497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMSY, a BRCA-2 partner in crime.
    Livingston DM
    Nat Med; 2004 Feb; 10(2):127-8. PubMed ID: 14760417
    [No Abstract]   [Full Text] [Related]  

  • 12. Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcome.
    Rodriguez C; Hughes-Davies L; Vallès H; Orsetti B; Cuny M; Ursule L; Kouzarides T; Theillet C
    Clin Cancer Res; 2004 Sep; 10(17):5785-91. PubMed ID: 15355907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry.
    Bane AL; Mulligan AM; Pinnaduwage D; O'Malley FP; Andrulis IL
    Breast Cancer Res Treat; 2011 Jun; 127(3):831-9. PubMed ID: 21327470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131.
    Varier RA; Carrillo de Santa Pau E; van der Groep P; Lindeboom RG; Matarese F; Mensinga A; Smits AH; Edupuganti RR; Baltissen MP; Jansen PW; Ter Hoeve N; van Weely DR; Poser I; van Diest PJ; Stunnenberg HG; Vermeulen M
    J Biol Chem; 2016 Apr; 291(14):7313-24. PubMed ID: 26841866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion.
    Marzio A; Kurz E; Sahni JM; Di Feo G; Puccini J; Jiang S; Hirsch CA; Arbini AA; Wu WL; Pass HI; Bar-Sagi D; Papagiannakopoulos T; Pagano M
    Cell; 2022 Jan; 185(1):169-183.e19. PubMed ID: 34963055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific Akt Family Members Impair Stress-Mediated Transactivation of Viral Promoters and Enhance Neuronal Differentiation: Important Functions for Maintaining Latency.
    Zhao J; Zhu L; Wijesekera N; Jones C
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.
    Brown LA; Irving J; Parker R; Kim H; Press JZ; Longacre TA; Chia S; Magliocco A; Makretsov N; Gilks B; Pollack J; Huntsman D
    Gynecol Oncol; 2006 Feb; 100(2):264-70. PubMed ID: 16236351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EMSY copy number variation in male breast cancers characterized for BRCA1 and BRCA2 mutations.
    Navazio AS; Rizzolo P; Silvestri V; Valentini V; Zelli V; Zanna I; Masala G; Bianchi S; Tommasi S; Palli D; Ottini L
    Breast Cancer Res Treat; 2016 Nov; 160(1):181-186. PubMed ID: 27628328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
    Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
    BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression and activation of Akt2 protein in oral squamous cell carcinoma.
    Iamaroon A; Krisanaprakornkit S
    Oral Oncol; 2009 Oct; 45(10):e175-9. PubMed ID: 19628421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.